Abstract : We examined the clinicopathological profiles and cellular characteristics of 10 cases of surgically resected primary small intestinal cancers excluding duodenal cancers . Histological examination revealed nine adenocarcinomas and one sarcomatoid carcinoma. Invasion depth was subserosal in five cases, serosal in four cases and to the adjacent transverse colon in the remaining case. Metastasis was present in lymph node in seven cases, in distant organs in six, and in the peritoneum in seven cases. Of the 10 cases, 7 underwent postoperative chemotherapy, and 6 of the eight traceable patients died from the disease mean period of survival : 386 days . Histomorphologically, eight of nine adenocarcinomas showed an intestinal phenotype unclassi able in the other in the upper layer, while in the lower layer, there showed an intestinal phenotype and ve a non-intestinal phenotyp. Immunohistochemistry revealed a mean positive rate in the upper / lower layers as follows : 93 / 86 and 38 / 29 by intestinal markers CDX2 and MUC2 ; 19 / 28 and 13 / 32 by pancreatobiliary markers CK7 and MUC1 ; and 4 / 19 and 2 / 9 by gastric markers MUC5AC and MUC6, respectively. Thus, the intestinal phenotype predominated in almost all small intestinal cancer in this study, although some showed a transformation to non-intestinal or hybrid phenotypes with tumor progression. Flexible management for the diversity and transformation of cellular characteristics is therefore recommended treating and diagnosing small intestinal cancers.
Introduction
Cancer of the small intestine is often not detected until it reaches an advanced stage due to the late presentation of symptoms and the difficulty in performing endoscopic examinations. Many cases are also unsuitable for radical resection or have postoperative cancer recurrence, making chemotherapy frequently appropriate as an adjuvant or multidisciplinary therapy. However, there are no established chemotherapy regimens speci c to small intestinal cancer as this cancer is extremely rare, comprising 2 of all cases of gastrointestinal malignancies 1, 2 and successful results have not yet been obtained 3 .
The need for personalized medicine is being increasingly considered. This involves medication selection and regimen determination based on the sensitivity of an individual s cancer cells to anti-cancer drugs or cancer cell-specific characteristics such as the presence of tumor-associated antigens. Although small intestinal cancer is generally considered to resemble colon cancer histomorphologically, the keratin pro les and genetic abnormalities of this disease differ from those of colon cancer [4] [5] [6] [7] [8] . The study focused on the cellular characteristics of small intestinal cancer, since few such studies have been done.
The aim of this study was to clarify the cellular characteristics of small intestinal cancer by histomorphological and immunohistochemical analyses. We expect that the results will be useful when considering the histogenesis of small intestinal cancer as well as for its diagnosis and treatment.
Materials and Methods

Case selection
We reviewed 65 cases of malignant small bowel neoplasms excluding duodenal tumors , unclassi ed cases 8 as follows ; one case in which the tumor was mainly located in the terminal ileum, but also involved the cecum ; one in which a tumor equally involved the jejunum and pancreas ; two in which a primary ileal carcinoma was suspected, but another carcinoma was observed concurrently in another organ colon ; and one in which it was dif cult to distinguish whether the tumor was a recurrence of gastric cancer after more than 5 postoperative recurrence-free years or a primary jejunal carcinoma. The subject of the present study were the 10 carcinoma cases 
Analysis of cellular characteristics
We conducted histological and immunohistochemical analyses for determining the cellular characteristics of adenocarcinoma cases.
Histological analysis
We classified the neoplastic glands histomorphologically into intestinal and non-intestinal 
Immunohistochemical analysis
Immunohistochemical staining was performed using an avidin-biotin complex detection Table 1 The patients included 6 males and 4 females with a mean age of 62 years age range : colon was observed in one case case 7 . In addition, lymph node metastasis, distant organ metastasis, and peritoneal metastasis were observed in 7 cases, 6 cases, and 7 cases, respectively. Postoperative chemotherapy was administered to 7 patients of which 6 were treated by TS1 alone or by a combination of TS1 and other agents, and 1 by FOLFOX. Postoperative prognoses were traceable in 8 cases. Tumor-related death occurred in 6 patients and they were identified with a mean survival period of 386 days range : 50-665 days . In the remaining 2 cases, one patient case 2 is alive 500 days after the surgery with recurrence and another patient case 1 is alive 1460 days after surgery without any recurrence treated with adjuvant chemotherapy .
Results
Clinicopathological characteristics
Cellular characteristics
All nine adenocarcinoma cases showed heterogeneous composite or combined cellular characteristics histomorphologically Figure 1 ; however, when classifying the dominant features into intestinal and non-intestinal phenotypes for each layer, 8 cases were classified as intestinal and 1 case as unclassifiable in the upper layer, whereas 3 cases were classified as intestinal, 5 cases as non-intestinal, and 1 as unclassifiable in the lower layer Table 1 . 
Discussion
The efficacy of chemotherapy administered for small intestinal cancer remains unknown because this cancer is extremely rare and many such cancers are detected once in a locally advanced or distantly metastasized status 1, 2, 9, 10 , as also observed in this study. Personalized medicine involves medication selection and regimen determination based on the cancer cellspecific chemotherapeutic sensitivity or characteristic phenotypes e.g., presence of tumorassociated antigens to improve chemotherapy efficacy. We believe that our study on the cellular characteristics of small intestinal cancer will be bene cial for developing future such chemotherapeutic strategies against small intestinal cancer.
Most case of small intestinal cancer adenocarcinoma studied herein were histomorphologically heterogeneous. Hence, we were forced to evaluate the cellular characteristics There are several histopathological differences between small intestinal cancer and colorectal cancer [4] [5] [6] [7] [8] . Poorly differentiated carcinoma and sarcomatoid carcinoma are sometimes observed in small intestinal cancers case 8 and case 10 in this study 9, [14] [15] [16] [17] , but such types are extremely rare in colorectal cancer. Small intestinal adenocarcinomas show expression of pancreatobiliary markers e.g. keratin 7, MUC1, and CA19-9 see Table 2 at a higher rate compared to colorectal adenocarcinomas. Chen and Wang. 4 reported that all small intestinal adenocarcinomas showed a variable degree of CK7 expression diffuse in 54 and focal in 46 ; in contrast, only 4 in this study showed focal expression in secondary colorectal adenocarcinomas. We also confirmed that only 7 4 of 169 colorectal adenocarcinomas exhibited a MUC1 positive cell ratio of 50 , while ratios this high were shown in 41 70 of 59 pancreatic adenocarcinomas and 3 30 of 10 small intestinal adenocarcino-mas 18 . Moreover, genetic abnormalities of colorectal cancer e.g., APC gene mutations do not always apply to small intestinal cancers 5, 6, 19 . With regard to the histogenesis, it remains controversial whether an adenomacarcinoma progression sequence, which is well described in colorectal cancer, is the major pathway in small intestinal cancer because few study have been done involving early stage lesions. Although adenomatous component were observed in the tumor periphery in two of the present cases, the phenotype was still difficult to discriminate from well-differentiated, low grade adenocarcinoma Chang et al described this as peritumoral dysplasia 9 . Thus, the adenomacarcinoma sequence was not proven in any case. In genetic susceptibility, no present cases involved hamartomatous or adenomatous polyps, suggestive of Peutz-Jeghers syndrome or familial adenomatous polyposis. Lynch syndrome was also not noted in any case, although the level of microsatellite instability MSI should be analyzed in future studies because high MSI rates of 10-25 have been already described in small intestinal cancers 11, [20] [21] [22] [23] .
In conclusion, this study of the clinicopathological features of small intestinal cancers 
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